The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 163:73-78, January 2006
doi: 10.1176/appi.ajp.163.1.73
© 2006 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Full Text (Publish Ahead of Print[PDF])
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Taylor, B. P.
* Articles by Quitkin, F. M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Taylor, B. P.
* Articles by Quitkin, F. M.
Related Collections
* Neurotransmitters
* Outpatient Services
* Depression
* Parkinson's Disease
* Antidepressants
*Related Article

Psychomotor Slowing as a Predictor of Fluoxetine Nonresponse in Depressed Outpatients

Bonnie P. Taylor, Ph.D., Gerard E. Bruder, Ph.D., Jonathan W. Stewart, M.D., Patrick J. McGrath, M.D., Jeffrey Halperin, Ph.D., Howard Ehrlichman, Ph.D., and Frederic M. Quitkin, M.D.

OBJECTIVE: This study examined the utility of baseline psychomotor speed, measured with neuropsychological tests, to predict fluoxetine response in moderately depressed outpatients. The authors hypothesized that since psychomotor slowing in depressed patients has been linked to reduced dopaminergic neurotransmission, patients with slowing would be unresponsive to fluoxetine, a selective serotonin reuptake inhibitor. METHOD: After baseline neuropsychological testing, patients were treated openly with fluoxetine for 12 weeks. Thirty-seven patients completed the trial. RESULTS: Compared to the 25 patients who responded, the 12 patients who did not respond to fluoxetine exhibited significantly poorer performance in verbal fluency on the Controlled Oral Word Association Test FAS and in color naming on the Stroop Color and Word Test. In addition, the nonresponders tended to perform worse than the responders on the Stroop Color and Word Test reading subtest and the WAIS-III digit symbol subtest. Differential treatment response was specific to psychomotor speed because responders and nonresponders did not perform differently on tasks of executive functioning, attention, visuospatial functioning, or verbal intelligence. CONCLUSIONS: Psychomotor slowing may identify a subgroup of depressed patients who have a dopaminergic deficit that is unresponsive to fluoxetine monotherapy and who should therefore receive an alternative treatment.


Related Article:

In This Issue
Am J Psychiatry 2006 163: 34. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Psychiatr. NewsHome page
J. Arehart-Treichel
SSRI Efficacy Reduced When Slow Psychomotor Skills Present
Psychiatr News, February 3, 2006; 41(3): 24 - 24.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org